Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch

Published 27/03/2023, 17:19

Benzinga - Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move.

High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard.

Related Link: What Is A Short Squeeze?

Unicycle Therapeutics Inc (NASDAQ: UNCY): Biotechnology company Unicycle moves up 37 positions on the leaderboard to rank first for the week. Data shows 39.6% of the float short and a cost to borrow of 241.1%. The stock got several analyst updates and price target increases in recent weeks on the heels of a funding round to help with the commercialization of lead drug Renazorb.

Kala Pharmaceuticals Inc (NASDAQ: KALA): Kala returns to the top five positions on the leaderboard with an 11-position jump for the week to rank second. Data shows 12.6% of the float short and a cost to borrow of 644.2%. Last week, the stock was 14.2% of the float short and a cost to borrow of 507%. The stock previously ranked in the top five of the leaderboard and appears to be trending up once again.

Bellerophon Therapeutics Inc (NASDAQ: BLPH): Shares of Bellerophon are up more than 500% in the last month, likely leading to an increased short interest in the clinical-stage biotech company. Data shows 14.7% of the float short and a cost to borrow of 188.1%. The stock moves up 274 positions to rank third on the leaderboard.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Compass Pathways PLC (NASDAQ: CMPS): Mental health company Compass Pathways moves up seven positions to rank fourth for the week. Data shows 33.8% of the float short and a cost to borrow of 20.7%. The company recently shared data from its Phase 2b study in patients with depression.

MicroAlgo Inc (NASDDAQ: MLGO): Ranking fifth for the week is MicroAlgo Inc, moving up five positions. Data shows 11.8% of the float short and a cost to borrow of 102.8%.

Stocks to Watch: Outside the top five short squeeze candidates, several other names are making big moves and could be ones to watch for investors.

PaxMedica Inc (NASDAQ: PXMD): Last week’s list topper PaxMedica moves down five positions to rank sixth. Data shows 43.7% of the float short and a cost to borrow of 427%.

Euda Health Holdings Ltd (NASDAQ: EUDA): Euda ranks seventh with a big jump of 1021 positions on the leaderboard. Data shows 9.1% of the float short and a cost to borrow of 255.2%.

Virgin Orbit Holdings Inc (NASDAQ: VORB): Space stock Virgin Orbit saw shares fall on financing concerns and the pausing of operations. Shares have since moved higher on reports of private financing. Data shows 12.7% of the float short and a cost to borrow of 48.1%. The stock moves up 32 positions to rank eighth for the week.

Getty Images Holdings Inc (NYSE: GETY): Content creator and image marketplace topped the short squeeze for several weeks before falling out of the top five. The stock ranks 10th for the week with 73.1% of the float short and a cost to borrow of 99%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Via Renewables Inc (NASDAQ: VIA): Natural gas and electricity company ranks 12th for the week moving up 123 positions. Data shows 65.3% of the float short and a cost to borrow of 0.9%.

Read Next: Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.